Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation - Stock Option Activity (Details)

v3.23.1
Stock-Based Compensation - Stock Option Activity (Details) - USD ($)
12 Months Ended
Sep. 02, 2021
Dec. 31, 2022
Dec. 31, 2021
Number of shares      
Granted (in shares) 1,132,290    
Equity Option      
Number of shares      
Beginning balance (in shares)   9,101,000,000  
Granted (in shares)   6,133,000,000  
Exercised (in shares)   (361,000,000)  
Forfeited options (in shares)   (1,290,000,000)  
Expired or cancelled options (in shares)   (1,544,000,000)  
Ending balance (in shares)   12,039,000,000 9,101,000,000
Exercisable (in shares)   5,918,000,000  
Weighted average exercise  price      
Beginning balance (in dollars per share)   $ 3.78  
Granted (in dollars per share)   6.31  
Exercised (in dollars per share)   3.73  
Forfeited options (in dollars per share)   5.37  
Expired or cancelled options (in dollars per share)   3.84  
Ending balance (in dollars per share)   4.90 $ 3.78
Exercisable (in dollars per share)   $ 4.05  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]      
Weighted average remaining contractual life, outstanding   7 years 4 months 9 days 6 years 4 months 6 days
Weighted average remaining contractual life, exercisable   5 years 9 months 25 days  
Aggregate intrinsic value   $ 0 $ 35,014
Exercisable, aggregate intrinsic value